Đang chuẩn bị liên kết để tải về tài liệu:
Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

High levels of thymidine kinase 1 (TK1) and thymidine phosphorylase (TYMP) are key molecular targets by thymidine therapeutics in cancer treatment. The dual roles of TYMP as a tumor growth factor and a key activation enzyme of anticancer metabolites resulted in a mixed outcome in cancer patients. In this study, we investigated the roles of TK1 and TYMP on a thymidine quinoxaline conjugate to evaluate an alternative to circumvent the contradictive role of TYMP. |

TÀI LIỆU LIÊN QUAN

Highly functionalized piperidines: Free radical scavenging, anticancer activity, DNA interaction and correlation with biological activity

A facile synthesis and anticancer activity of some novel thiazoles carrying 1,3,4-thiadiazole moiety

Molecular docking and biological evaluation of some thioxoquinazolin‑4(3H)‑one derivatives as anticancer, antioxidant and anticonvulsant agents

An insight into the therapeutic potential of piperazine-based anticancer agents

Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: A review

Phytofabrication of biomolecule-coated metallic silver nanoparticles using leaf extracts of in vitro-raised bamboo species and its anticancer activity against human PC3 cell lines

Prediction of physicochemical properties and anticancer activity of similar structures of flavones and isoflavones

Synthesis of thiophene derivatives and their anti-microbial, antioxidant, anticorrosion and anticancer activity

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents

Synthesis and anticancer activity of novel quinazolinone‑based rhodanines
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.